Walleye Trading
KRYS icon

Walleye Trading’s Krystal Biotech KRYS Stock Holding History

Walleye Trading’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,900
Closed -$611K – 4386
2024
Q4 		$611K Buy
3,900
+1,000
+34% +$177K ﹤0.01% 2485
2024
Q3 		$528K Buy
+2,900
New +$559K ﹤0.01% 2492
2024
Q2 		– Sell
-2,100
Closed -$374K – 4624
2024
Q1 		$374K Buy
+2,100
New +$292K ﹤0.01% 3008
2023
Q3 		– Sell
-2,500
Closed -$294K – 5183
2023
Q2 		$294K Sell
2,500
-1,500
-38% -$153K ﹤0.01% 3169
2023
Q1 		$320K Buy
+4,000
New +$314K ﹤0.01% 3179
2022
Q1 		– Sell
-10,400
Closed -$727K – 5621
2021
Q4 		$727K Buy
10,400
+3,400
+49% +$198K ﹤0.01% 2557
2021
Q3 		$365K Buy
+7,000
New +$414K ﹤0.01% 3253

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Walleye Trading's KRYS Position: Q1 2025 in Review

Walleye Trading sold out of Krystal Biotech (KRYS) in Q1 2025, closing a stake of 393 shares — an estimated $61.6K sold.

Walleye Trading first reported a position in KRYS in Q2 2021 and held it in 2 quarters. The position peaked at $61.6K in Q4 2024. 299 funds tracked by Wall St. Rank hold KRYS as of Q1 2025.

  • Walleye Trading reported no remaining Krystal Biotech position as of Q1 2025 after selling out during the quarter.
  • Walleye Trading sold 393 Krystal Biotech shares in Q1 2025, an estimated $61.6K.
  • Walleye Trading first reported a position in Krystal Biotech in Q2 2021 and held it in 2 quarters.
  • Walleye Trading's Krystal Biotech position peaked at $61.6K in Q4 2024.
  • 299 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2025.

Based on Walleye Trading's 13F filing for Q1 2025, filed 14 May 2025.